Daniel Rodel's Contact Details

Daniel Rodel's Company Details

GlycoEra AG

Schlieren, Zurich, Switzerland • 21 Employees
Research

GlycoEra AG is advancing glycoengineered therapeutics to address unmet medical needs. Despite significant advancements in understanding the role of glycans in human health and diseases, this knowledge has not translated well into therapeutic drug development, a consequence of the limitations and complexities of controlling glycosylation processes. GlycoEra's platform has overcome these challenges! The CustomGlycan Platform enables glycan-mediated modes of action through the engineering of highly defined specific glycan structures, accessing a novel combinatorial dimension for the treatment of very challenging diseases.Get in touch with us if you would like to be part of this amazing new era in therapeutic drug development!